Brief Summary

This is an expanded access designed to provide access to dasatinib for eligible participants.

Available
Individual Patients

Drug: Dasatinib

Countries
Australia
Belgium
Brazil
Canada
France
Italy
Latvia
Liberia
Mexico
Spain
United States
Locations

Local Institution
New York, New York, 10065

Available

Investigator: Site 0024

Local Institution
Charlottesville, Virginia, 22908

Available

Investigator: Site 003

Contacts

Recruiting sites have contact information. Please contact the sites directly. If there is no contact information,
please email:
Clinical.Trials@bms.com

First line of the email MUST contain NCT # and Site #.

Bristol-Myers Squibb
Study Director
Bristol-Myers Squibb

Bristol-Myers Squibb
NCT Number
MeSH Terms
Dasatinib